TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 28850471

Group type: EXPERIMENTAL
Intervention: 2mg morphine into inflamed tissue
Number of subjects: 88

Group type: COMPARATOR
Intervention: 2mg morphine into non-inflamed tissue
Number of subjects: 88

Group type: COMPARATOR
Intervention: IM morphine
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Sedation scores
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Time to first analgesic intake
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Serious side effects
Number of subjects: 88
Study: 24685276

Group type: EXPERIMENTAL
Intervention: Fingolimod 0.5 mg
Number of subjects: 1083

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1083
Study: 22712480

Group type: EXPERIMENTAL
Intervention: Plasma F₂‐isoprostanes (F₂‐IsoPs)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Isofurans (IsoFs)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: F₂‐IsoPs
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: IsoFs
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: WC, SBP, and sex
Number of subjects: 233
Study: 20427088

Group type: EXPERIMENTAL
Intervention: 0.5 mg ranibizumab + prompt laser
Number of subjects: 691

Group type: EXPERIMENTAL
Intervention: 0.5 mg ranibizumab + deferred laser
Number of subjects: 691

Group type: EXPERIMENTAL
Intervention: 4 mg triamcinolone + prompt laser
Number of subjects: 691

Group type: COMPARATOR
Intervention: sham injection + prompt laser
Number of subjects: 691
Study: 18227475

Group type: EXPERIMENTAL
Intervention: Insulin pump therapy (CSII)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Long-acting insulin analogs (glargine and detemir)
Number of subjects: 0
Study: 15522901

Group type: EXPERIMENTAL
Intervention: Low-to-moderate intensity pre-conditioning exercise programme linked with exercise counselling
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (no exercise programme)
Number of subjects: 96
Study: 12576840

Group type: EXPERIMENTAL
Intervention: Acupuncture to points of the kidney-bladder distinct meridian
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Acupuncture to points not expected to treat the prostate
Number of subjects: 30

Group type: COMPARATOR
Intervention: Observation for 3 months
Number of subjects: 30
Study: 10560985

Group type: EXPERIMENTAL
Intervention: Crinone vaginal progesterone gel (90 mg once daily)
Number of subjects: 206

Group type: COMPARATOR
Intervention: IM progesterone (50 mg once daily)
Number of subjects: 206
Study: 8904262

Group type: EXPERIMENTAL
Intervention: Total intravenous anesthesia with propofol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Inhalation anesthesia with nitrous oxide and isoflurane
Number of subjects: 50
Study: 1870360

Group type: EXPERIMENTAL
Intervention: clebopride + simethicone (Flatoril)
Number of subjects: 0
Study: 31689480

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicines (Fufang Chuanxiong Capsule and Xinyue Capsule)
Number of subjects: 426

Group type: COMPARATOR
Intervention: Western medicine standard therapy
Number of subjects: 426
Study: 30419066

Group type: EXPERIMENTAL
Intervention: Exposure to a musically-enriched environment (listening to music at home, during play, or attending concerts)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Exposure to a musically-enriched environment
Number of subjects: 176
Study: 27761657

Group type: EXPERIMENTAL
Intervention: HIT (3‐min intervals at 40 and 80 % VO2max for five repetitions, n = 20)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: HIT
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: MCT (sustained 60 % VO2max, n = 20)
Number of subjects: 60

Group type: COMPARATOR
Intervention: CTL (control group, n = 20)
Number of subjects: 60
Study: 24565955

Group type: EXPERIMENTAL
Intervention: Atrasentan (bone targeted endothelin-A receptor antagonist)
Number of subjects: 778

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 778
Study: 22316089

Group type: EXPERIMENTAL
Intervention: LGS-On (low glucose suspend feature turned on)
Number of subjects: 50

Group type: COMPARATOR
Intervention: LGS-Off (continued insulin delivery regardless of SG value)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: LGS-On
Number of subjects: 50

Group type: COMPARATOR
Intervention: LGS-Off
Number of subjects: 50
Study: 20658925

Group type: EXPERIMENTAL
Intervention: Crushed ice in a room temperature wet towel
Number of subjects: 25

Group type: COMPARATOR
Intervention: Liquid Ice
Number of subjects: 25
Study: 18619520

Group type: EXPERIMENTAL
Intervention: Hypobaric chamber at 4000m altitude
Number of subjects: 10
Study: 15762941

Group type: EXPERIMENTAL
Intervention: Novel items (new materials not presented earlier in Phase 1)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Familiar items (materials encoded earlier in Phase 1)
Number of subjects: 0
Study: 12446370

Group type: EXPERIMENTAL
Intervention: Dexamethasone phosphate 0.1%
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium 0.1%
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo (saline 0.9%)
Number of subjects: 180
Study: 10521964

Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg every 3 hours
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg every 6 hours
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Omeprazole 80 mg every 12 hours
Number of subjects: 20
Study: 8541198

Group type: EXPERIMENTAL
Intervention: Subcuticular Maxon
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Interrupted nylon
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Continuous nylon
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Clips
Number of subjects: 114

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 114
Study: 1685793

Group type: EXPERIMENTAL
Intervention: Suriclone (0.1 mg tid)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Suriclone (0.2 mg tid)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Suriclone (0.3 mg tid)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Suriclone (0.4 mg tid)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Diazepam (5 mg tid)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 6814226

Group type: COMPARATOR
Intervention: Verapamil
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Withdrawal of Verapamil
Number of subjects: 63
Study: 30911917

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (CHM)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Non-CHM control group
Number of subjects: 47
Study: 29847468

Group type: EXPERIMENTAL
Intervention: Ketamine (1 to 2 mg/kg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Methohexital (1 to 2 mg/kg)
Number of subjects: 50
Study: 26781292

Group type: EXPERIMENTAL
Intervention: Interactive mobile App (Strengthen your ankle)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Regular written exercise materials (Booklet)
Number of subjects: 220
Study: 24745863

Group type: EXPERIMENTAL
Intervention: Trigger point acupuncture (TrP)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Sham acupuncture (SH)
Number of subjects: 18
Study: 21664707

Group type: EXPERIMENTAL
Intervention: RVEF 30-39%
Number of subjects: 822

Group type: EXPERIMENTAL
Intervention: RVEF 20-29%
Number of subjects: 822

Group type: EXPERIMENTAL
Intervention: RVEF <20%
Number of subjects: 822

Group type: COMPARATOR
Intervention: RVEF ≥ 40%
Number of subjects: 822
Study: 19396947

Group type: EXPERIMENTAL
Intervention: Nebivolol (5 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Metoprolol (50 mg/day)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nebivolol
Number of subjects: 30
Study: 16406475

Group type: EXPERIMENTAL
Intervention: Brief health counseling, self-help materials on smoking cessation during pregnancy and early postpartum, and a partner booklet.
Number of subjects: 118

Group type: COMPARATOR
Intervention: Routine care (control group).
Number of subjects: 118
Study: 14700340

Group type: EXPERIMENTAL
Intervention: 25% EDTA gel applied for 15 seconds
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 25% EDTA gel applied for 1 minute
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 25% EDTA gel applied for 3 minutes
Number of subjects: 0
Study: 10965426

Group type: EXPERIMENTAL
Intervention: Topical dexpanthenol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 0
Study: 8854787

Group type: EXPERIMENTAL
Intervention: 5‐FU + MMC +/‐ ADR (group I)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: CDDP + MMC +/‐ 5‐FU (group II)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: IAIC with radiotherapy
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: IAIC without radiotherapy
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: All cases
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: CR cases
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Internal iliac arteries placement
Number of subjects: 97
Study: 1337833

Group type: EXPERIMENTAL
Intervention: Etoposide in lomustine cycles
Number of subjects: 79

Group type: COMPARATOR
Intervention: Methotrexate in lomustine cycles
Number of subjects: 79
Study: 6392216

Group type: EXPERIMENTAL
Intervention: Mashed potatoes
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Polished rice
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: White beans
Number of subjects: 13
Study: 31220570

Group type: EXPERIMENTAL
Intervention: RCTs considered clinically replicable
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: RCTs with absent information
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: RCTs with less well described information
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: RCTs with best described information
Number of subjects: 47
Study: 29070025

Group type: EXPERIMENTAL
Intervention: Daylight photodynamic therapy (DL-PDT) with methyl aminolevulinate (MAL), 5 treatments over 18 months, with daylight exposure for 2 hours after MAL application.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cryosurgery (control group), lesion-directed at the first visit and at visits 2 to 5 if necessary.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daylight photodynamic therapy (DL-PDT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cryosurgery (control group)
Number of subjects: 0
Study: 26312936

Group type: EXPERIMENTAL
Intervention: Triclabendazole (TCBZ) 7.5mg/kg administered in two doses with a 12-hour interval (Group I)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Triclabendazole (TCBZ) 10mg/kg administered as a single dose (Group II)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Both groups (Group I and Group II)
Number of subjects: 84
Study: 23937441

Group type: EXPERIMENTAL
Intervention: Low Glycemic Index (LGI) snack bar
Number of subjects: 14

Group type: COMPARATOR
Intervention: High Glycemic Index (HGI) snack bar
Number of subjects: 14
Study: 21632810

Group type: EXPERIMENTAL
Intervention: Oral ergocalciferol (50,000 IU)
Number of subjects: 12
Study: 19629889

Group type: EXPERIMENTAL
Intervention: Intravenous PUFA (100 mg fish oil/kg body weight/day)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group (100 mg soya oil/kg body weight/day)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Intravenous PUFA
Number of subjects: 102

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 102
Study: 16388789

Group type: EXPERIMENTAL
Intervention: Professional road cyclists
Number of subjects: 85

Group type: COMPARATOR
Intervention: Sedentary controls
Number of subjects: 85
Study: 15599086

Group type: EXPERIMENTAL
Intervention: game‐with‐music
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: music‐only
Number of subjects: 0

Group type: COMPARATOR
Intervention: game‐without‐music
Number of subjects: 0
Study: 11829208

Group type: EXPERIMENTAL
Intervention: Amisulpride at a dose of 100 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9492495

Group type: EXPERIMENTAL
Intervention: Ulinastatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 7803945

Group type: EXPERIMENTAL
Intervention: Treatment with bendroflumethiazide (2.5 mg/day, with possible doubling of dosage)
Number of subjects: 2100

Group type: EXPERIMENTAL
Intervention: Treatment with lisinopril (2.5 mg/day, with possible doubling of dosage)
Number of subjects: 2100

Group type: EXPERIMENTAL
Intervention: Treatment with slow release diltiazem (120 mg/day, increasing to 240 mg/day if required)
Number of subjects: 2100

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 2100
Study: 3190040

Group type: EXPERIMENTAL
Intervention: High-dose cyclosporin A (10 mg/kg body weight.d)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Low-dose cyclosporin A (1 mg/kg.d)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Nephrotoxicity
Number of subjects: 31
Study: 29778251

Group type: EXPERIMENTAL
Intervention: Group-based Tai chi (TC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0
Study: 28499440

Group type: EXPERIMENTAL
Intervention: Extended Brief Intervention (EBI) - five weekly sessions and one follow-up at 8 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 30
Study: 26203062

Group type: EXPERIMENTAL
Intervention: Erectile dysfunction
Number of subjects: 1244

Group type: EXPERIMENTAL
Intervention: Lower urinary tract symptoms (LUTS)
Number of subjects: 1244

Group type: EXPERIMENTAL
Intervention: Sexual dysfunction in women
Number of subjects: 1244

Group type: EXPERIMENTAL
Intervention: Urinary incontinence (UI) and LUTS combined in women
Number of subjects: 1244

Group type: EXPERIMENTAL
Intervention: Urologic complications
Number of subjects: 1244
Study: 23601259

Group type: EXPERIMENTAL
Intervention: Group A (stylet replacement before needle removal)
Number of subjects: 630

Group type: COMPARATOR
Intervention: Group B (needle removal without stylet replacement)
Number of subjects: 630
Study: 21556731

Group type: EXPERIMENTAL
Intervention: S1 nerve root stimulation
Number of subjects: 25
Study: 18705518

Group type: EXPERIMENTAL
Intervention: Modified type of retention elements (M group) with an adams clasp added in the position of central incisors.
Number of subjects: 18

Group type: COMPARATOR
Intervention: Traditional type of retention elements (T group).
Number of subjects: 18
Study: 16580422

Group type: EXPERIMENTAL
Intervention: Trimetazidine (TMZ) 20 mg three times a day for 4 weeks
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Trimetazidine (TMZ)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 12656697

Group type: EXPERIMENTAL
Intervention: Meal-stimulated gastric acid secretion in subjects with gastro-oesophageal reflux disease
Number of subjects: 85

Group type: COMPARATOR
Intervention: Meal-stimulated gastric acid secretion in healthy controls
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Correlation between meal-stimulated gastric secretion and integrated gastric acidity
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Correlation between oesophageal acidity and integrated gastric acidity
Number of subjects: 85
Study: 11134120

Group type: COMPARATOR
Intervention: Calcium supplementation (exact dosage not specified)
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Calcium intake (1000 mg difference)
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Calcium intake
Number of subjects: 780
Study: 9172848

Group type: EXPERIMENTAL
Intervention: Psychosocial factors (higher state anxiety, lower anger outward, more past life events, lower expectations of future life events) in nonactive medication group (n = 263)
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Increases in past life events and depression from baseline to first follow-up
Number of subjects: 348
Study: 8396989

Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 2822797

Group type: EXPERIMENTAL
Intervention: Enalapril 5 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31863680

Group type: EXPERIMENTAL
Intervention: Fish consumption
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Fish intake
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: TMAO
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High dietary fat intake in males
Number of subjects: 10
Study: 29347887

Group type: EXPERIMENTAL
Intervention: Cryo-assisted tumor resection en bloc with peritumoral tracer injection (blue dye)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Palliative tumor cryoablation in situ with intratumoral tracer injection (blue dye)
Number of subjects: 17
Study: 28153938

Group type: COMPARATOR
Intervention: CTRL+DS (unrestricted breathing with 0.6-l dead space)
Number of subjects: 11

Group type: COMPARATOR
Intervention: CTRL (unrestricted breathing at 90% gas exchange threshold)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: CWS+DS (chest wall strapping with 0.6-l dead space)
Number of subjects: 11

Group type: COMPARATOR
Intervention: CWS (chest wall strapping at 90% GET)
Number of subjects: 11
Study: 24419772

Group type: EXPERIMENTAL
Intervention: Risk score based on clinical signs/symptoms and complete blood count (CBC) data
Number of subjects: 125
Study: 22248163

Group type: EXPERIMENTAL
Intervention: Simplex T (tobramycin-laden) cement
Number of subjects: 23

Group type: COMPARATOR
Intervention: Simplex P (standard) cement
Number of subjects: 23
Study: 19403954

Group type: EXPERIMENTAL
Intervention: Red Bull Energy Drink (ED; 2.0 g taurine, 1.2 g glucuronolactone, 160 mg caffeine, 54 g carbohydrate, 40 mg niacin, 10 mg pantothenic acid, 10 mg vitamin B6, and 10 microg vitamin B12)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Red Bull Energy Drink (ED)
Number of subjects: 12
Study: 17985956

Group type: EXPERIMENTAL
Intervention: 20 mg sustained release morphine
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 15908668

Group type: EXPERIMENTAL
Intervention: Home-based physical activity (PA) intervention for early-stage breast cancer patients
Number of subjects: 86

Group type: COMPARATOR
Intervention: Contact control group
Number of subjects: 86
Study: 12043868

Group type: EXPERIMENTAL
Intervention: 2.5% sodium hypochlorite and Glyde File Prep (group C)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 2.5% sodium hypochlorite and Glyde File Prep applied at the end of the preparation with sterile paper points (group D)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Physiological solution (group A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 2.5% sodium hypochlorite (group B)
Number of subjects: 40
Study: 11928421

Group type: EXPERIMENTAL
Intervention: Implant retained overdentures (IRD)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Complete dentures (CD)
Number of subjects: 151
Study: 7667819

Group type: EXPERIMENTAL
Intervention: Aspirin (200 mg thrice daily, with meals)
Number of subjects: 459

Group type: EXPERIMENTAL
Intervention: Triflusal (300 mg thrice daily, with meals)
Number of subjects: 459

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 459
Study: 2140380

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 341967

Group type: EXPERIMENTAL
Intervention: Iris clip lens implantation after intracapsular cataract extraction
Number of subjects: 62

Group type: COMPARATOR
Intervention: Intracapsular extraction only
Number of subjects: 62
Study: 30517087

Group type: EXPERIMENTAL
Intervention: RE40%1RM
Number of subjects: 12

Group type: COMPARATOR
Intervention: CONT40%
Number of subjects: 12

Group type: COMPARATOR
Intervention: CONT80%
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: RE80%1RM
Number of subjects: 12
Study: 28202786

Group type: EXPERIMENTAL
Intervention: Sulpiride (dopaminergic antagonist)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bromocriptine (dopaminergic agonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25799193

Group type: EXPERIMENTAL
Intervention: Ground fish (952 mg of elemental calcium)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Limestone (920 mg of elemental calcium)
Number of subjects: 96
Study: 23374907

Group type: EXPERIMENTAL
Intervention: Communication training (early intervention group, EI)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Communication training (late intervention group, LI)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison intervention (early intervention group, EI)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison intervention (late intervention group, LI)
Number of subjects: 30
Study: 21546602

Group type: EXPERIMENTAL
Intervention: Simulator-supported training
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional training
Number of subjects: 45
Study: 19577352

Group type: EXPERIMENTAL
Intervention: Recurrent peritonitis episodes
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Relapsing peritonitis episodes
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (first peritonitis episodes)
Number of subjects: 125
Study: 16728218

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES) implantation followed by treatment for restenosis with bare metal stent implantation, balloon dilatation, or intravascular brachytherapy; 82% received bare metal stent implantation, 13.5% balloon dilatation, and 4.5% intravascular brachytherapy.
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Traditional percutaneous coronary intervention for SES failure.
Number of subjects: 22
Study: 16176337

Group type: COMPARATOR
Intervention: Antihypertensive medicines
Number of subjects: 28997
Study: 12939217

Group type: EXPERIMENTAL
Intervention: Inhalation of hypoxic gas mixture corresponding to an altitude of 4500 m (controls)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Inhalation of hypoxic gas mixture corresponding to an altitude of 2500 m (CAD patients)
Number of subjects: 18
Study: 10425945

Group type: EXPERIMENTAL
Intervention: Nickel‐titanium hand files
Number of subjects: 60

Group type: COMPARATOR
Intervention: Stainless‐steel K‐files
Number of subjects: 60
Study: 7572678

Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg once daily
Number of subjects: 9014

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9014
Study: 2075121

Group type: EXPERIMENTAL
Intervention: Pirenzepine (50 mg p.o.)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14